Tuesday, Sep 29, 2020 | Last Update : 04:32 AM IST

188th Day Of Lockdown

Maharashtra1339232103001535571 Andhra Pradesh6756746050905708 Tamil Nadu5808085251549313 Karnataka5755664622418582 Uttar Pradesh3870853258885594 Delhi2711142366515235 West Bengal2474252169214781 Odisha209374173571850 Telangana1872111564311107 Bihar178882164537888 Kerala175385117917678 Assam169985139977655 Gujarat1332191132403417 Rajasthan1288591077181441 Haryana1237821059901307 Madhya Pradesh117588932382207 Punjab107096840253134 Chhatisgarh9856566860777 Jharkhand7770964515661 Jammu and Kashmir69832495571105 Uttarakhand4533233642555 Goa3107125071386 Puducherry2548919781494 Tripura2412717464262 Himachal Pradesh136799526152 Chandigarh112128677145 Manipur9791760263 Arunachal Pradesh8649623014 Nagaland5768469311 Meghalaya5158334343 Sikkim2707199431 Mizoram178612880
  Business   Companies  13 Aug 2020  India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

REUTERS
Published : Aug 13, 2020, 11:01 am IST
Updated : Aug 13, 2020, 11:01 am IST

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

 Zydus Cadila launched the cheapest generic version of Gilead Sciences’ antiviral drug remdesivir in India. (Photo- Twitter)
  Zydus Cadila launched the cheapest generic version of Gilead Sciences’ antiviral drug remdesivir in India. (Photo- Twitter)

BENGALURU: Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences’ antiviral drug remdesivir in India to treat COVID-19 following reports of shortages at hospitals in the world’s third-worst hit nation.

Zydus has priced it at 2,800 rupees ($37.44) per 100mg vial. It will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients, the company said in a regulatory filing.

 

Officials in some Indian states had a few weeks ago complained of supply issues, but a top executive at drugmaker Cipla Ltd had earlier this week said the supplies were stabilising.

Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd.

Gilead has also entered into licensing agreements with Dr. Reddy’s Laboratories Ltd and Syngene International Ltd to make remdesivir for distribution in 127 countries, including India.

India has reported a daily jump of more than 50,000 coronavirus infections for two weeks, with total cases as of Wednesday at 2.33 million.

 

Tags: zydus cadila, gilead sciences, antiviral drug, remdesivir, india, covid-19
Location: India, Karnataka, Bengaluru